CIK 0001422143
- Non-accelerated filer
- Smaller reporting company
Kura Oncology, Inc.
Sign in to watch- Ticker
- KURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 611547851
- Phone
- +1 858-500-8800
- Business address
- 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
- Former names
- ZETA ACQUISITION CORP III
- Open-market buys, last 90 days
- $4,248,530
- in 3 filings
- Open-market sales, last 90 days
- $1,310,361
- in 7 filings, $252K under 10b5-1 plans
Net +$2,938,169. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- WILSON TROY EDWARD +$4.2M President and CEO 3 filings
- Leoni Mollie −$440K Chief Medical Officer sold 23% of stake
- Powl Brian T. −$397K Chief Commercial Officer sold 21% of stake
- Burrows Francis −$225K Chief Scientific Officer sold 33% of stake
- FORD KATHLEEN −$112K Chief Operating Officer sold 7% of stake
Reading 38 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-11 | WILSON TROY EDWARD President and CEO | Exercise or conversion | +1,185 | $6.15 | $7K | 27,226 |
| 2020-02-11 | WILSON TROY EDWARD President and CEO | Exercise or conversion | +26,911 | $4.80 | $129K | 54,137 |
| 2020-02-11 | WILSON TROY EDWARD President and CEO | Exercise or conversion · Option to purchase common stock | −1,185 | 234,815 | ||
| 2020-02-11 | WILSON TROY EDWARD President and CEO | Exercise or conversion · Option to purchase common stock | −26,911 | 39,063 | ||
| 2020-02-10 | Martell Bridget A Acting Chief Medical Officer | Grant or award · Option to purchase common stock | +50,000 | 50,000 | ||
| 2020-02-10 | Martell Bridget A Acting Chief Medical Officer | Grant or award · Option to purchase common stock | +50,000 | 50,000 | ||
| 2020-01-30 | FORD KATHLEEN Chief Operating Officer | Grant or award · Option to purchase common stock | +45,393 | 45,393 | ||
| 2020-01-30 | GRASSO MARC CFO, CBO | Grant or award · Option to purchase common stock | +111,723 | 111,723 | ||
| 2020-01-30 | WILSON TROY EDWARD President and CEO | Grant or award · Option to purchase common stock | +393,950 | 393,950 | ||
| 2020-01-06 | FLOWERS KIRSTEN Chief Commercial Officer | Grant or award · Option to purchase common stock | +250,000 | 250,000 | ||
| 2019-11-04 | BASTA JAMES Chief Legal Officer | Grant or award · Option to purchase common stock | +175,000 | 175,000 | ||
| 2019-10-14 | Parks Diane L. Director | Grant or award · Option to purchase common stock | +30,000 | 30,000 | ||
| 2019-10-14 | Parks Diane L. Director | Grant or award · Option to purchase common stock | +8,666 | 8,666 | ||
| 2019-08-09 | FORD KATHLEEN Chief Operating Officer | Grant or award · Option to purchase common stock | +250,000 | 250,000 | ||
| 2019-07-10 | GUALBERTO ANTONIO Head of Development & CMO | Exercise or conversion | +18,000 | $6.15 | $111K | 357,973 |
| 2019-07-10 | GUALBERTO ANTONIO Head of Development & CMO | Sale | −18,000 | $21.11 | $380K | 339,973 |
| 2019-07-10 | GUALBERTO ANTONIO Head of Development & CMO | Exercise or conversion · Option to purchase common stock | −18,000 | 151,000 | ||
| 2019-06-25 | Szela Mary T Director | Grant or award · Option to purchase common stock | +13,000 | 13,000 | ||
| 2019-06-25 | Stein Steven H Director | Grant or award · Option to purchase common stock | +13,000 | 13,000 | ||
| 2019-06-25 | Malley Thomas Director | Grant or award · Option to purchase common stock | +13,000 | 13,000 |
Page 17 of 19 · 366 trades